Clinical Trials Directory

Trials / Completed

CompletedNCT04453215

Laser Therapy for Patients With Systemic Lupus Erythematosus

The Effect of Dental Laser Therapy for Patients With Systemic Lupus Erythematosus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
91 (actual)
Sponsor
Dr. Merve Benli · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease that has detrimental effects on connective tissue and other organs. The musculoskeletal system is one of the most affected systems in this group of patients including the temporomandibular joint. The most common symptoms when muscle involvement in SLE are muscle atrophy decreased muscle strength and myopathy. SLE activity and long-term corticosteroid use are thought to be responsible for these symptoms, thus, SLE patients are accepted to be at higher risk for temporomandibular joint disorders (TMD). Low-level laser therapy(LLLT) is frequently used in the treatment of TMD due to its pain relief and anti-inflammatory effect. Thus, in this study, LLLT has been used to evaluate this treatment modality on the chewing function and pain values of SLE patients with myogenic TMD.

Conditions

Interventions

TypeNameDescription
DEVICEGaAlAs semiconductor diode laser devicelow-level laser therapy

Timeline

Start date
2019-01-12
Primary completion
2019-12-23
Completion
2020-03-15
First posted
2020-07-01
Last updated
2021-11-10

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04453215. Inclusion in this directory is not an endorsement.